Bejelentkezés Regisztrálj ingyen

Theratechnologies EPS

Mi az Theratechnologies EPS?

A EPS az Theratechnologies, Inc. - -0.12

Mi a EPS meghatározása?



Az egy részvényre jutó nyereség (EPS) az a társaság nyereségének a része, amely a törzsrészvények minden egyes fennálló részesedéséhez tartozik. A hígításhoz igazodik, és a tizenkét hónap után kiszámítjuk.

Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.

EPS a Health Care szektor a TSX-on cégekben a Theratechnologies -hoz képest

Mit csinál Theratechnologies?

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

eps -hoz hasonló cégek Theratechnologies